Hjem › Gliom › Illinois › Chicago
Gliom kliniske forsøg i Chicago, IL
13 studier for Gliom søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RekruttererFase 1/2
- University of Chicago Comprehensive Cancer Center, Chicago
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservationsstudie
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RekruttererFase 3
- University of Chicago, Chicago
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RekruttererFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
RekruttererFase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekruttererFase 1/2
- Research Site, Chicago
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
RekruttererFase 1
- Northwestern Medicine, Chicago
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
RekruttererFase 1/2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- Northwestern Memorial Hospital, Chicago
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
RekruttererFase 1
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Gliom forsøg i andre byer
- New York City, NY25 studier
- Houston, TX23 studier
- Boston, MA20 studier
- Washington, DC19 studier
- Philadelphia, PA16 studier
- Miami, FL15 studier
- Columbus, OH15 studier
- San Francisco, CA14 studier
- Durham, NC12 studier
- Seattle, WA11 studier
- Los Angeles, CA10 studier
- St. Louis, MO10 studier
Andre studier i Chicago
- Ikke-småcellet lungecancer61 studier
- Brystkræft58 studier
- Kræft (alle typer)51 studier
- Metastatisk cancer45 studier
- Prostatakræft45 studier
- Overvægt41 studier
- Lungecancer41 studier
- Ægstockræft36 studier
- Slagtilfælde34 studier
- Colorektal kræft33 studier
- Hjertesvigt31 studier
- Overvægt28 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.